Rashidian et al. showed it could be used to PEGylate Glucose-Dependent Insulinotropic Polypeptide (GIP), a small protein (~7 kDa) that has been investigated for the treatment of type 2 diabetes. Here, GIP is linked to type 2 diabetes mellitus.